Cargando…
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth most common cancer among men in South Korea, where the prevalence of chronic hepatitis B infection is high in middle and old age. The current practice guidelines will provide useful and sensible advice for the cl...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597235/ https://www.ncbi.nlm.nih.gov/pubmed/36263666 http://dx.doi.org/10.3350/cmh.2022.0294 |
Ejemplares similares
-
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Publicado: (2023) -
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Publicado: (2022) -
Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
por: Yoon, Ja Kyung, et al.
Publicado: (2023) -
Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
por: Kang, Hyo-Jin, et al.
Publicado: (2023) -
Impact of the updated KLCA-NCC criteria for diagnosis of “probable HCC” in liver MRI: comparisons between KLCA v2022 and v2018
por: Yoon, Jeong Hee
Publicado: (2023)